{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/chickenpox/management/breastfeeding-woman/","result":{"pageContext":{"chapter":{"id":"c659257f-8875-5440-ae24-57c071cf226c","slug":"breastfeeding-woman","fullItemName":"Scenario: Breastfeeding woman","depth":2,"htmlHeader":"<!-- begin field 7e3b6d5c-1e0c-4968-bed8-b82df3a4e551 --><h2>Scenario: Breastfeeding woman</h2><!-- end field 7e3b6d5c-1e0c-4968-bed8-b82df3a4e551 -->","summary":"Covers the management of a breastfeeding woman with chickenpox.","htmlStringContent":"<!-- begin item af07a36f-bb9b-4008-aa4f-bf7cdead3cc5 --><!-- begin field 6ab5655d-9770-4e9d-adf1-acbc0159b911 --><p>From age 12 years to 60 years (Female).</p><!-- end field 6ab5655d-9770-4e9d-adf1-acbc0159b911 --><!-- end item af07a36f-bb9b-4008-aa4f-bf7cdead3cc5 -->","topic":{"id":"5d1b7a44-f7ff-52e9-a218-c53ecadb0e4c","topicId":"4960f8a4-0140-4c3b-9bd0-b1ac6fccd648","topicName":"Chickenpox","slug":"chickenpox","lastRevised":"Last revised in August 2018","chapters":[{"id":"fe0450ab-ddfd-5960-bb47-b986d9cc6059","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ff90f80f-13d4-5732-8d09-9c5566ce6ec2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"16ae9969-1384-5b7b-aff0-1ac19aeee530","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"10059b43-4a23-59cf-8f5f-31f8d5e8e3c9","slug":"changes","fullItemName":"Changes"},{"id":"5f0098ae-9d37-5658-9379-66477733f220","slug":"update","fullItemName":"Update"}]},{"id":"9d70228e-0283-5d34-a4af-5237097d0a02","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"fa1d46ea-9d63-5d1a-b60c-9b96e87f802c","slug":"goals","fullItemName":"Goals"},{"id":"4e21e939-92fd-555c-a175-93b8a626169a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ea18d1e8-0bdd-542f-a985-2952ecabca2d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5d911096-5b50-551b-a17a-cff3070315b0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"601f7c68-386e-5474-96f1-d6239bd81750","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"305e8fa8-8eb6-5b69-a902-93019e0c2c17","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bb9b11dc-3295-5e2b-9798-37bb8b6ebbc0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"145f102c-4e0f-52c9-8b3b-e0b5c6eb112e","slug":"definition","fullItemName":"Definition"},{"id":"9f4d0cad-78a8-568f-831e-8878d2f4bfd3","slug":"transmission","fullItemName":"Transmission"},{"id":"5691920a-f618-5a98-ab32-417dfc782db1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"eb6a66b5-2006-5968-a97d-52de72842cbf","slug":"complications","fullItemName":"Complications"}]},{"id":"a3eb8e9b-cdd9-5243-8353-09aac3fdc322","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ff9f70a8-0c29-5357-946d-bbca67eafbbf","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b651c5b4-34df-5480-b05d-909c9023a7a5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3844af91-e26b-515e-a645-9725d2f54810","fullItemName":"Management","slug":"management","subChapters":[{"id":"7700c175-994a-51d5-a2d0-36eb7478e2c1","slug":"child-or-adult","fullItemName":"Scenario: Child or adult"},{"id":"f6a62aa2-354d-5eee-a868-fb5d162115ef","slug":"pregnant-woman","fullItemName":"Scenario: Pregnant woman"},{"id":"c659257f-8875-5440-ae24-57c071cf226c","slug":"breastfeeding-woman","fullItemName":"Scenario: Breastfeeding woman"},{"id":"499e6045-af39-5bc4-952b-edcb6b29144f","slug":"neonate","fullItemName":"Scenario: Neonate"},{"id":"dac00668-b032-569c-8b5a-260c2f1625b3","slug":"immunocompromised","fullItemName":"Scenario: Immunocompromised"},{"id":"072ae3a5-9cf4-5233-bca1-2d46e53de42b","slug":"exposure-to-chickenpox","fullItemName":"Scenario: Exposure to chickenpox"}]},{"id":"fa12b54d-0c95-5ee8-8884-219ac7a9dd2a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a2d64426-afb7-5590-998d-3ed0d13b78d2","slug":"chlorphenamine","fullItemName":"Chlorphenamine"},{"id":"17d5cf92-3449-52d5-932c-f1b770061787","slug":"aciclovir","fullItemName":"Aciclovir"}]},{"id":"95550d9e-6be2-5a94-924a-c4c2f8e7dbe4","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"880099bb-bff8-543e-a1e8-267413ef45b9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c80905f1-b771-5170-8be8-c1bcee935552","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"6bf66548-b486-53e1-bce7-d9bb45af9bea","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"52168b40-dab0-5afb-9662-bb28014b5734","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5fa2da47-e83a-5886-9c1b-c6ae4e97a0a7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"769ea126-78ac-540c-a1c9-38446d44e22e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"87e1772a-0cd8-5e0c-ad7a-b676a65171bb","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3844af91-e26b-515e-a645-9725d2f54810","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"e010d33a-d4c1-564d-a50b-a6f8658fd402","slug":"managing-a-breastfeeding-woman","fullItemName":"Managing a breastfeeding woman","depth":3,"htmlHeader":"<!-- begin field cddc94df-184d-45f4-bb71-7f7bdc6078ea --><h3>How should I manage a breastfeeding woman with chickenpox?</h3><!-- end field cddc94df-184d-45f4-bb71-7f7bdc6078ea -->","summary":null,"htmlStringContent":"<!-- begin item 8a7c3608-17bc-4f03-8565-f6f75b35b16d --><!-- begin field badab85c-099e-4596-aeb4-b1047ee895fc --><ul><li>Admit the woman to hospital if serious complications (for example pneumonia or encephalitis) are suspected.</li><li>For all other breastfeeding women:<ul><li>Consider prescribing aciclovir if the woman presents within 24 hours of rash onset, particularly if she has severe chickenpox or is at increased risk of complications.</li><li>Seek urgent specialist advice regarding whether she should continue to breastfeed and whether her baby requires treatment to minimize the risk of complications.</li><li>Offer <a class=\"topic-reference internal-reference\" href=\"/topics/chickenpox/management/breastfeeding-woman/#treating-symptoms-in-breastfeeding\">symptomatic treatment</a>.</li><li>Give <a class=\"topic-reference internal-reference\" href=\"/topics/chickenpox/management/breastfeeding-woman/#advice-for-a-breastfeeding-woman-with-chickenpox\">advice</a> about contact with other people and when to seek medical advice.</li><li>If a high temperature develops (particularly after initial improvement) with redness and pain surrounding the chickenpox lesions, consider bacterial superinfection and manage accordingly. </li></ul></li></ul><!-- end field badab85c-099e-4596-aeb4-b1047ee895fc --><!-- end item 8a7c3608-17bc-4f03-8565-f6f75b35b16d -->","subChapters":[{"id":"b81ef8c2-263e-50a8-a25a-c6e4f52e5a81","slug":"basis-for-recommendation-cfc","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c343a470-e1bc-42bc-a108-5a701d83d563 --><h4>Basis for recommendation</h4><!-- end field c343a470-e1bc-42bc-a108-5a701d83d563 -->","summary":null,"htmlStringContent":"<!-- begin item cfc748b8-b5bd-4953-a57f-14e802c7dffc --><!-- begin field 550e0614-dd28-4cec-8193-cea30d8f833e --><h5>Admission to hospital</h5><ul><li>This recommendation is pragmatic, based on what CKS considers to be good clinical practice and the fact that chickenpox can be more severe in adults compared with children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">PHE, 2015</a>].</li></ul><h5>Antiviral treatment</h5><ul><li>The recommendation on the groups for whom aciclovir should be considered is based on expert opinion in a Public Health England document: <em>Management of infection guidance for primary care for consultation and local adaptation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">PHE, 2016b</a>] and supported by expert opinion in the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BNF 72, 2016</a>]. Adults are more likely to develop complications of chickenpox than children. Smokers and people with severe lung or cardiovascular disease, or those with a chronic skin disorder, are particularly at risk from complicated chickenpox [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">PHE, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BNF 72, 2016</a>].<ul><li>A review by BMJ Clinical Evidence (search date January 2014) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Cohen and Breuer, 2015</a>] found a systematic review of three randomized controlled trials, of which two studies compared the use of aciclovir with placebo in otherwise healthy adults with chickenpox (n = 148). The findings were that:<ul><li>Aciclovir given within 24 hours of rash onset reduced the time to full crusting of lesions and reduced the number of lesions.</li><li>Aciclovir given more than 24 hours after rash onset showed no significant difference in time to full crusting of lesions or time to no new lesions.</li></ul></li><li>CKS found no recent trials looking specifically at the effect of aciclovir on preventing complications of chickenpox in an adult population.</li></ul></li><li>Aciclovir is present at low concentrations in breastmilk and is not expected to adversely affect the infant and is considered to be the antiviral of choice for breastfeeding women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">LactMed, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">SPS, 2016</a>].<strong> </strong>However, the British National Formulary and manufacturer's Summary of Product Characteristics advise using aciclovir with caution in breastfeeding women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">ABPI, 2016c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BNF 72, 2016</a>]. </li></ul><h5>Seeking urgent specialist advice about whether a mother should continue to breastfeed</h5><ul><li>CKS advises seeking specialist advice regarding whether a mother with chickenpox should breastfeed in view of the risk of the infant developing chickenpox, and advice from the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BNF 72, 2016</a>] and the manufacturer's Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">ABPI, 2016c</a>] to use aciclovir when breastfeeding 'with caution'.<ul><li>Recommendations on breastfeeding from the Health Protection Agency's <em>Guidance on the management of rash illness and exposure to rash illness in pregnancy</em> state that: if the mother has chickenpox, she should be allowed to breastfeed. If lesions are close to the nipple, milk should be expressed from the affected side until lesions have crusted. This milk can be fed to the baby if he or she is covered by varicella-zoster immunoglobulin and/or aciclovir [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">HPA, 2011</a>]. These treatments should be initiated by a specialist.</li></ul></li></ul><h5>Offering symptomatic treatment</h5><ul><li>This recommendation is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Gould, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BMJ Best Practice, 2016</a>] and what CKS considers to be good clinical practice.</li></ul><h5>Giving advice</h5><ul><li>This recommendation is pragmatic, and is based on what CKS considers to be good clinical practice.</li></ul><h5>Bacterial superinfection</h5><ul><li>The recommendation to consider the possibility of bacterial superinfection is based on a case review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Sturgeon et al, 2015</a>] and one UK study (n = 613) that found that 32% of children and 17% of adults admitted to hospital with chickenpox had secondary bacterial skin infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Bovill and Bannister, 1998</a>]. </li></ul><!-- end field 550e0614-dd28-4cec-8193-cea30d8f833e --><!-- end item cfc748b8-b5bd-4953-a57f-14e802c7dffc -->","subChapters":[]}]},{"id":"7905d674-65eb-5cc8-ae41-1c225bd971be","slug":"advice-for-a-breastfeeding-woman-with-chickenpox","fullItemName":"Advice for a breastfeeding woman with chickenpox","depth":3,"htmlHeader":"<!-- begin field 5132d14e-f91f-477c-a8c4-694477121fe0 --><h3>What advice should I give a breastfeeding woman with chickenpox?</h3><!-- end field 5132d14e-f91f-477c-a8c4-694477121fe0 -->","summary":null,"htmlStringContent":"<!-- begin item dc80bd58-d40f-4621-a76e-437e8af40258 --><!-- begin field 31549ff7-9036-4f6a-b56f-7a98d40860df --><ul><li><strong>Advise the following simple measures to help alleviate symptoms:</strong><ul><li>Encourage adequate fluid intake to avoid dehydration.</li><li>Dress appropriately to avoid overheating or shivering.</li><li>Wear smooth, cotton fabrics.</li><li>Keep nails short to minimize damage from scratching.</li></ul></li><li><strong>Advise that the most infectious period is 1–2 days before the rash appears, </strong>but infectivity continues until all the lesions have crusted over (usually about 5 days after the onset of the rash).<ul><li>During this time, advise a person with chickenpox to avoid contact with:<ul><li>People who are immunocompromised (for example those receiving cancer treatment or high doses of oral steroids, or those with conditions that reduce immunity).</li><li>Pregnant women.</li><li>Infants aged 4 weeks or less.</li></ul></li></ul></li><li><strong>Inform the woman to seek urgent medical advice if her condition deteriorates or she develops <a class=\"topic-reference internal-reference\" href=\"/topics/chickenpox/background-information/complications/\">complications</a>. </strong></li></ul><!-- end field 31549ff7-9036-4f6a-b56f-7a98d40860df --><!-- end item dc80bd58-d40f-4621-a76e-437e8af40258 -->","subChapters":[{"id":"76618025-e9fc-5349-84ea-67abea6e5ebd","slug":"basis-for-recommendation-c92","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field b06fb8dc-db53-4cb3-bd62-473861509541 --><h4>Basis for recommendation</h4><!-- end field b06fb8dc-db53-4cb3-bd62-473861509541 -->","summary":null,"htmlStringContent":"<!-- begin item c925f45a-af26-4e2f-b541-9157cf5e4f4d --><!-- begin field 1ab380ac-1524-402d-b91a-6b6432dbabe9 --><h5>Self-care measures</h5><ul><li>The recommendations on self-care measures for symptomatic relief are based on review articles on the management of chickenpox<strong> </strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Allen, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BMJ Best Practice, 2016</a>].</li></ul><h5>Advice on contacts</h5><ul><li>This recommendation is based on information on the infectious period of chickenpox and groups at increased risk of complications of chickenpox in <em>Immunisation against infectious disease</em>: 'the Green book', published by Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">PHE, 2015</a>]<strong> </strong>and a guideline from the Royal College of Obstetricians and Gynaecologists on Chickenpox in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">RCOG, 2015</a>].</li></ul><h5>Seeking medical advice</h5><ul><li>This recommendation is pragmatic and is based on what CKS considers to be good clinical practice and expert opinion in <em>Immunisation against infectious disease:</em> 'the Green book', published by Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">PHE, 2015</a>]. </li></ul><!-- end field 1ab380ac-1524-402d-b91a-6b6432dbabe9 --><!-- end item c925f45a-af26-4e2f-b541-9157cf5e4f4d -->","subChapters":[]}]},{"id":"e2d3ca79-c95d-5f17-bfe1-4c5716cace15","slug":"treating-symptoms-in-breastfeeding","fullItemName":"Treating symptoms in breastfeeding","depth":3,"htmlHeader":"<!-- begin field cecc1e9a-80e2-4eb3-a9ce-398407effb7f --><h3>Treating symptoms in a breastfeeding woman</h3><!-- end field cecc1e9a-80e2-4eb3-a9ce-398407effb7f -->","summary":null,"htmlStringContent":"<!-- begin item bacb6c4e-f2ea-496c-95f6-ea4e6433b88c --><!-- begin field 23ccf503-c058-49cc-ac25-03288d785d99 --><ul><li>Consider offering:<ul><li>Paracetamol if pain or fever are causing distress (avoid nonsteroidal anti-inflammatory drugs). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.</li><li>Topical calamine lotion to alleviate itch.</li></ul></li><li>Chlorphenamine is not recommended for the management of the itch of chickenpox in a breastfeeding woman.</li></ul><!-- end field 23ccf503-c058-49cc-ac25-03288d785d99 --><!-- end item bacb6c4e-f2ea-496c-95f6-ea4e6433b88c -->","subChapters":[{"id":"00eb4457-ee7a-573a-83ee-bdb477cf285f","slug":"basis-for-recommendation-98d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 85a181a6-fcbc-49d3-b52d-29b05e994f2d --><h4>Basis for recommendation</h4><!-- end field 85a181a6-fcbc-49d3-b52d-29b05e994f2d -->","summary":null,"htmlStringContent":"<!-- begin item 98de9974-29a6-4800-b133-52b972d8e621 --><!-- begin field ca841813-f8c0-4df7-8807-fb49d6492f52 --><h5>Paracetamol and ibuprofen</h5><ul><li>The recommendation to use paracetamol is extrapolated from a guideline from the National Institute for Health and Care Excellence: <em>Fever in under 5's: assessment and initial management 2013 </em>and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Gould, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BMJ Best Practice, 2016</a>]. Paracetamol is not considered to be harmful in breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BNF 72, 2016</a>].</li><li>CKS has not recommended the use of nonsteroidal anti-inflammatory drugs (NSAIDs) because of concerns that use of NSAIDs in children with varicella is associated with an increased risk of severe skin and soft tissue infections (usually caused by group A streptococcus and <em>Staphylococcus aureus</em>) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">UKMi, 2016</a>]. This is supported by expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Gould, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BMJ Best Practice, 2016</a>].<ul><li>A literature review by UK Medicines Information found a number of cohort and case-control studies and case series suggesting an association between use of NSAIDs in children with chickenpox and severe skin reactions. Although the confounding factor of the increased likelihood of NSAIDs being required for children with severe cases of chickenpox or complications was noted, on the basis of the available evidence the authors recommended avoiding NSAIDs in children with chickenpox. Paracetamol was recommended as the preferred alternative treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">UKMi, 2016</a>]. </li><li>The risk of skin reactions in adults with chickenpox using NSAIDs is unclear as most of the available trials involved children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">UKMi, 2016</a>]. Until further evidence is available, CKS recommends avoiding NSAIDs such as ibuprofen in adults with chickenpox, in line with expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Gould, 2014</a>].</li></ul></li></ul><h5>Calamine lotion</h5><ul><li>Calamine lotion is thought to relieve itch by evaporating from the skin to induce a cooling effect [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Allen, 2006</a>].</li><li>CKS found no evidence on the use of calamine lotion to treat itch in chickenpox, however it is considered to be an option as it is recommended by the authors of some review articles and there is anecdotal evidence to support its use [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Allen, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Tebruegge et al, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">Gould, 2014</a>]. Some experts state that it can dry the skin and increase itch [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">BMJ Best Practice, 2016</a>]. </li><li>There is no available evidence on the safety of calamine lotion during pregnancy and lactation, however it has been used for many years with no reports of adverse effects [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">ABPI, 2015a</a>].</li></ul><h5>Antihistamines</h5><ul><li>Although Piriton<sup>®</sup> (but not generic chlorphenamine) is licensed for relief of itching associated with chickenpox [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">ABPI, 2016a</a>], there is very limited evidence to support the use of topical or systemic antihistamines in relieving pruritus in people with chickenpox.</li><li>Given the lack of evidence of effectiveness and the manufacturer's Summary of Product Characteristics stating that chlorphenamine may inhibit lactation, may be secreted in breast milk, and should only be used for breastfeeding women if considered essential [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chickenpox/references/\">ABPI, 2016d</a>], CKS does not recommend its use in breastfeeding women.</li></ul><h5>Topical crotamiton and oatmeal bath additives</h5><ul><li>CKS found no evidence to justify the use of topical crotamiton and colloidal oatmeal bath additives in chickenpox.</li></ul><!-- end field ca841813-f8c0-4df7-8807-fb49d6492f52 --><!-- end item 98de9974-29a6-4800-b133-52b972d8e621 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}